K-604
CAS No. 217094-32-1
K-604 ( K604 )
Catalog No. M13469 CAS No. 217094-32-1
K-604 is a potent, selective and competitive ACAT-1 inhibitor with IC50 of 0.45 uM for human ACAT-1, displays 229-fold selectivity over ACAT-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 67 | Get Quote |
|
5MG | 110 | Get Quote |
|
10MG | 177 | Get Quote |
|
25MG | 357 | Get Quote |
|
50MG | 530 | Get Quote |
|
100MG | 759 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameK-604
-
NoteResearch use only, not for human use.
-
Brief DescriptionK-604 is a potent, selective and competitive ACAT-1 inhibitor with IC50 of 0.45 uM for human ACAT-1, displays 229-fold selectivity over ACAT-2.
-
DescriptionK-604 is a potent, selective and competitive ACAT-1 inhibitor with IC50 of 0.45 uM for human ACAT-1, displays 229-fold selectivity over ACAT-2; inhibits cholesterol esterification in human monocyte-derived macrophages with IC50 of 60 nM, enhances cholesterol efflux from THP-1 macrophages to HDL3 or apolipoprotein A-I; suppresses the development of atherosclerosis in an animal model without affecting plasma cholesterol levels.Atherosclerosis Phase 2 Clinical
-
SynonymsK604
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaCardiovascular Disease
-
IndicationAtherosclerosis
Chemical Information
-
CAS Number217094-32-1
-
Formula Weight575.63
-
Molecular FormulaC23H32Cl2N6OS3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC(=C(C(=N1)SC)NC(=O)CN2CCN(CC2)CCSC3=NC4=CC=CC=C4N3)SC.Cl.Cl
-
Chemical Name4-[2-(1H-Benzimidazol-2-ylthio)ethyl]-N-[6-methyl-2,4-bis(methylthio)-3-pyridinyl]-1-piperazineacetamide dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ikenoya M, et al. Atherosclerosis. 2007 Apr;191(2):290-7.
2. Shibuya Y, et al. J Neurosci. 2014 Oct 22;34(43):14484-501.
3. Yoshinaka Y, et al. Atherosclerosis. 2010 Nov;213(1):85-91.
2. Shibuya Y, et al. J Neurosci. 2014 Oct 22;34(43):14484-501.
3. Yoshinaka Y, et al. Atherosclerosis. 2010 Nov;213(1):85-91.
molnova catalog
related products
-
Sodium Nitroprusside
Sodium Nitroprusside is a potent vasodilator working through releasing NO spontaneously in blood.
-
Lupanine
Lupanine has a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity. Lupanine improves glucose homeostasis by influencing KATP-channels of pancreatic beta cells.
-
Hydrazinium hydroxid...
Hydrazinium hydroxide is a bioactive compound.